A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
Fulminant myocarditis due to COVID-19
We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize cases presenting with few symptoms. What is already known about this...
The rapid surge and wide spread of the coronavirus disease-2019 (COVID-19) overshadows the entire medical industries worldwide. The stringent medical resources hinder the diagnostic capacity globally, while 84 000 of new cases confirmed...
Disasters and pandemics pose unique challenges to health care delivery. As health care resources continue to be stretched due to the increasing burden of the coronavirus disease (COVID-19) pandemic, telemedicine, including tele-education,...
Guillain-Barré syndrome related to COVID-19 infection
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brought with it rapid development of both molecular and serologic assays for identification of COVID-19 infections. While Food and Drug Administration (FDA)...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause coronavirus disease 2019 (COVID-19), an influenza-like disease that is primarily thought to infect the lungs with transmission through the respiratory route. However,...
Guillain-Barré syndrome associated with SARS-CoV-2 infection
Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive